Random-ass Drugs Flashcards
(73 cards)
povidone-iodine (Betadine)
surgical hand scrub option if allergic to chlorhexidine
daprodustat (Jesduvroq)
oral ESA indicated for CKD patients who have been receiving dialysis for at least four months
adefovir (Hepsera)
nucleoside/tide reverse transcriptase inhibitor for hepatitis B
terlipressin (Terlivaz)
vasopressin analog for hepatorenal syndrome
cholera-PO (Vaxchora)
live-attenuated vaccine; caused by Vibrio cholerae and causes rice-water stools
typhoid-PO (Vivotif)
live-attenuated vaccine; caused by Salmonella typhi; spread by contaminated food/water
yellow fever-SC (YF-VAX)
live-attenuated vaccine; patient provided yellow card (ICVP) for country entry valid 10 days after date of vaccination
plazomicin (Zemdril)
last-line IV aminoglycoside for complicated UTI
tedizolid (Sivextro)
PO/IV oxazolidinone for SSTI
chloramphenicol
reversible 50-S binder with activity against Gram+/-/anaerobe/atypical; rarely used due to Aes (blood dyscrasias and Gray syndrome)
secnidazole (Solosec)
granule packet related to metronidazole
lefamulin (Xenleta)
first-in-class pleuromutilin that inhibits bacterial protein synthesis by binding to the 50S
omadacycline (Nuzyra)
approved for CAP
isavuconazonium (Cresemba)
prodrug of isavuconazole; requires a filter and causes QT shortening
anidulafungin (Eraxis)
echinocandin (inhibits beta (1,3)-D-glucan) injection for candidemia or esophageal candidiasis; no renal dose adjustment
oteseconazole (Vivjoa)
for recurrent vulvovaginal candidiasis
griseofulvin
for fungal infections of the skin, hair and nails
baloxavir marboxil (Xofluza)
endonuclease inhibitor for influenza treatment and prophylaxis (>5 years)
foscarnet (Foscavir)
injection for cytomegalovirus treatment; boxed warning for renal impairment
letermovir (Prevymis)
tablet/injection for cytomegalovirus prophylaxis
maraviroc (Selzentry)
blocks HIV from binding CD4 cells in virus strains that use the CCR6 co-receptor; requires tropism assay (does not work in CXCR4 or mixed co-receptors)
fostemsavir (Rukobia)
converts to temsavir which binds to the gp120 subunit of HIV envelope proteins inhibiting interaction between virus and CD4 host cell
ibalizumab-uiyk (Trogarzo)
moAb that binds to CD4 domain blocking viral entry
lenacapavir (Sunleca)
inhibits multiple stages of HIV life cycle (capsid inhibitor)